Pulmocide

0 followers


Pulmocide is focused on the development of inhaled medicines for the treatment of viral and fungal infections of the respiratory tract.

Employees

11-50

Links

Org chart

Dan Burgess
Chairman & CEO

Dan Burgess

Collapse
Pete Strong
Chief Scientific Officer & Co-Founder
Lance Berman
Chief Medical Officer
Jennifer Giottonini Cayer
Chief Business Officer & Head of Corporate Development
Ashish Sagrolikar
Chief Commercial Officer
David Mantus
President, US Operations
Ubaldo Martin
VP of Clinical Development
Sonya Roeloffzen Stokowski
VP & Head of Global Regulatory Affairs
Anne Brindley
MD of UK & Head of CMC